Department of General Surgery, The First Affiliated Hospital of Ningbo University, Ningbo, China.
Department of Urology Surgery, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, Zhejiang, China.
Front Immunol. 2023 Jun 9;14:1183088. doi: 10.3389/fimmu.2023.1183088. eCollection 2023.
Recently, the incidence rate of renal fibrosis has been increasing worldwide, greatly increasing the burden on society. However, the diagnostic and therapeutic tools available for the disease are insufficient, necessitating the screening of potential biomarkers to predict renal fibrosis.
Using the Gene Expression Omnibus (GEO) database, we obtained two gene array datasets (GSE76882 and GSE22459) from patients with renal fibrosis and healthy individuals. We identified differentially expressed genes (DEGs) between renal fibrosis and normal tissues and analyzed possible diagnostic biomarkers using machine learning. The diagnostic effect of the candidate markers was evaluated using receiver operating characteristic (ROC) curves and verified their expression using Reverse transcription quantitative polymerase chain reaction (RT-qPCR). The CIBERSORT algorithm was used to determine the proportions of 22 types of immune cells in patients with renal fibrosis, and the correlation between biomarker expression and the proportion of immune cells was studied. Finally, we developed an artificial neural network model of renal fibrosis.
Four candidate genes namely DOCK2, SLC1A3, SOX9 and TARP were identified as biomarkers of renal fibrosis, with the area under the ROC curve (AUC) values higher than 0.75. Next, we verified the expression of these genes by RT-qPCR. Subsequently, we revealed the potential disorder of immune cells in the renal fibrosis group through CIBERSORT analysis and found that immune cells were highly correlated with the expression of candidate markers.
DOCK2, SLC1A3, SOX9, and TARP were identified as potential diagnostic genes for renal fibrosis, and the most relevant immune cells were identified. Our findings provide potential biomarkers for the diagnosis of renal fibrosis.
最近,全球范围内肾纤维化的发病率一直在上升,这大大增加了社会的负担。然而,现有的诊断和治疗工具还不够完善,因此需要筛选潜在的生物标志物来预测肾纤维化。
我们使用基因表达综合数据库(GEO),从患有肾纤维化的患者和健康个体中获得了两个基因芯片数据集(GSE76882 和 GSE22459)。我们鉴定了肾纤维化组织和正常组织之间的差异表达基因(DEGs),并使用机器学习分析了可能的诊断生物标志物。使用接收者操作特征(ROC)曲线评估候选标记物的诊断效果,并使用逆转录定量聚合酶链反应(RT-qPCR)验证其表达。使用 CIBERSORT 算法确定患有肾纤维化患者中 22 种免疫细胞的比例,并研究生物标志物表达与免疫细胞比例之间的相关性。最后,我们开发了肾纤维化的人工神经网络模型。
确定了 4 个候选基因,即 DOCK2、SLC1A3、SOX9 和 TARP,作为肾纤维化的生物标志物,ROC 曲线下面积(AUC)值均高于 0.75。接下来,我们通过 RT-qPCR 验证了这些基因的表达。随后,通过 CIBERSORT 分析,我们揭示了肾纤维化组中免疫细胞潜在的紊乱,并发现免疫细胞与候选标志物的表达高度相关。
DOCK2、SLC1A3、SOX9 和 TARP 被鉴定为肾纤维化的潜在诊断基因,并且确定了最相关的免疫细胞。我们的研究结果为肾纤维化的诊断提供了潜在的生物标志物。